AKBA Akebia Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ 10-K/10-Q Aug 5, 2026
$0.69
· of 52w range
· above low
· to high
$0.5452w low
$3.2052w high
Market Cap (MRQ)
$189M
P/E (TTM)
-6.3
EPS (TTM)
$-0.11
Revenue (TTM)
$219M
your badges
52W Range
$1–$3
Analyst Rating
BUY
Price Target
$4
P/E
-6.3
ROE
-109.4%
Net Profit Margin
-13.5%
Your badge strip is empty — pin a metric anywhere on this page.
AKBA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.69
Market Cap (MRQ)
$189M
P/E (TTM)
-6.3
EPS (TTM)
$-0.11
Revenue (TTM)
$219M
ROE (TTM)
-109.4%
Debt/Equity (MRQ)
2.0
52W Range
$1–$3
AKBA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$236M2020-12-31 → 2025-12-31
EPS$-0.022020-12-31 → 2025-12-31
Free Cash Flow$68M2020-12-31 → 2025-12-31
Net margin-13.5%2020-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | AKBA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -6.35Y avg ≈-22.9 | ≈-22.9 | · | · | |
| P/S (TTM) | 0.95Y avg ≈1.9 | ≈1.9 | 46.7 | Undervalued | |
| P/B (MRQ) | 7.55Y avg ≈-1.2 | ≈-1.2 | 2.1 | Overvalued | |
| EV / EBITDA | 2.15Y avg ≈-0.3 | ≈-0.3 | · | · | |
| Price / FCF (TTM) | 4.75Y avg ≈-4.8 | ≈-4.8 | · | · | |
| Price / Cash Flow (TTM) | 4.55Y avg ≈-4.8 | ≈-4.8 | · | · | |
| EV / Revenue | 0.25Y avg ≈1.7 | ≈1.7 | · | · | |
| EV / FCF | 0.75Y avg ≈-5.3 | ≈-5.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | AKBA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -6.9%5Y avg ≈-18.2% | ≈-18.2% | -303.8% | Top tier | |
| EBITDA Margin | 10.0%5Y avg ≈-18.1% | ≈-18.1% | -264.9% | Top tier | |
| Pretax Margin (TTM) | -12.7%5Y avg ≈-26.0% | ≈-26.0% | -1019.0% | Top tier | |
| Net Profit Margin (TTM) | -13.5%5Y avg ≈-26.1% | ≈-26.1% | -839.4% | Top tier | |
| ROA (TTM) | -8.5%5Y avg ≈-17.2% | ≈-17.2% | -27.6% | Top tier | |
| ROE (TTM) | -109.4%5Y avg ≈90.2% | ≈90.2% | -22.4% | Top tier | |
| ROIC | 41.7% | · | -40.8% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | AKBA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 2.05Y avg ≈-0.1 | ≈-0.1 | 0.0 | High debt | |
| Current Ratio (MRQ) | 1.45Y avg ≈1.4 | ≈1.4 | 8.8 | Low liquidity | |
| Quick Ratio | 1.45Y avg ≈1.1 | ≈1.1 | 6.9 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 1.05Y avg ≈0.0 | ≈0.0 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | AKBA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 47.5%5Y avg ≈8.6% | ≈8.6% | · | · | |
| Revenue CAGR 3Y | -6.9%5Y avg ≈-9.6% | ≈-9.6% | · | · | |
| Revenue CAGR 5Y | -4.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | AKBA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.85Y avg ≈0.7 | ≈0.7 | 0.1 | Top tier | |
| Inventory Turnover | 2.55Y avg ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover | 5.85Y avg ≈5.6 | ≈5.6 | 4.5 | Top tier | |
| Revenue / Employee | ≈$1.2M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
49.6%
Next Report
Nov 09, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 5, 2026 | $-0.03 | $-0.04 | 33.2% |
| March 31, 2026 | May 11, 2026 | $-0.03 | $-0.03 | -4.9% |
| Dec. 31, 2025 | $-0.05 | $-0.03 | -96.1% | |
| Sept. 30, 2025 | $0.00 | $-0.02 | 100.0% | |
| June 30, 2025 | $0.00 | $-0.02 | 100.0% | |
| March 31, 2025 | $0.03 | $-0.05 | 165.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Cost of Revenue | $39M | $63M | $74M | $86M | $151M | $296M | $145M | $8M | · | · | · | · | |
| R&D Expense | $62M | $38M | $63M | $130M | $148M | $218M | $323M | $291M | $231M | $116M | $43M | $23M | |
| SG&A Expense | $107M | $107M | $100M | $139M | $174M | $154M | $149M | $87M | $27M | $22M | $18M | $15M | |
| Operating Expenses | $173M | $147M | $167M | $288M | $325M | $376M | $476M | $378M | $258M | $138M | $62M | $38M | |
| Operating Income | $23M | $-50M | $-46M | $-81M | $-265M | $-378M | $-286M | $-178M | $-77M | $-136M | $-62M | $-38M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $901.0K | $510.0K | $206.0K | |
| Other Non-op | $58.0K | $94.0K | $887.0K | $3M | $2M | $2M | $-794.0K | $81.0K | $204.0K | $-188.0K | $287.0K | $700.0K | |
| Pretax Income | $-4M | $-69M | $-52M | $-94M | $-282M | $-385M | $-286M | $-172M | $-74M | $-136M | · | · | |
| Income Tax | $2M | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | · | · | · | · | |
| Net Income | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| EPS (Basic) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| EPS (Diluted) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| Shares (Basic) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| Shares (Diluted) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| EBITDA | $23M | $-50M | $-46M | $-79M | $-263M | $-374M | $-284M | $-177M | $-79M | $-136M | $-62M | $-38M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $185M | $52M | $43M | $90M | $150M | $229M | $147M | $105M | $70M | $187M | $50M | $33M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $248M | $73M | $89M | $76M | |
| Receivables | $47M | $34M | $39M | $40M | $52M | $27M | $39M | $17M | $34M | $34M | · | $48.0K | |
| Inventory | $16M | $16M | $16M | $22M | $37M | $61M | $116M | $114M | · | · | · | · | |
| Prepaid Expense | $5M | $11M | $20M | $33M | $33M | $15M | $7M | $16M | $6M | $2M | $3M | $2M | |
| Other Current Assets | $4M | $7M | $6M | $17M | · | · | · | · | · | · | · | · | |
| Current Assets | $253M | $114M | $118M | $185M | $271M | $371M | $310M | $468M | $358M | $296M | $141M | $110M | |
| PP&E (Net) | $1M | $2M | $4M | $5M | $7M | $9M | $10M | $8M | $4M | $3M | $540.0K | $210.0K | |
| PP&E (Gross) | · | · | · | $15M | $14M | $14M | $14M | $10M | $5M | $3M | $687.0K | $261.0K | |
| Accum. Depreciation | · | · | · | $9M | $8M | $6M | $4M | $2M | $1M | $442.0K | $147.0K | $51.0K | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $55M | $55M | $55M | · | · | · | · | |
| Intangibles | · | $0 | $36M | $72M | $108M | $144M | $291M | $328M | · | · | · | · | |
| Other Non-current Assets | $60M | $37M | $12M | $5M | $50M | $38M | $76M | $137M | $2M | $1M | $1M | $305.0K | |
| Total Assets | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Accounts Payable | $21M | $15M | $15M | $18M | $34M | $41M | $39M | $43M | $7M | $2M | $2M | $2M | |
| Accrued Liabilities | $122M | $63M | $68M | $76M | $109M | $131M | $129M | $151M | $52M | $30M | $10M | $5M | |
| Current Liabilities | $163M | $81M | $100M | $130M | $261M | $187M | $208M | $266M | $141M | $114M | $12M | $7M | |
| Capital Leases | $0 | $4M | $9M | $29M | $34M | $25M | $28M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $5M | $9M | $16M | $84M | $61M | $30M | $30M | $22.0K | $27.0K | $5.0K | $32.0K | |
| Total Liabilities | $344M | $270M | $272M | $351M | $455M | $397M | $376M | $361M | $242M | $232M | $12M | $7M | |
| Long-term Debt | $48M | $39M | $35M | $66M | $98M | $96M | $76M | · | · | · | · | · | |
| Total Debt | $48M | $39M | $35M | · | $98M | $96M | $76M | · | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-1.68B | $-1.68B | $-1.61B | $-1.56B | $-1.46B | $-1.18B | $-794M | $-514M | $-371M | $-297M | $-161M | $-101M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $162.0K | $162.0K | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $13.0K | $0 | $-261.0K | $-442.0K | $-42.0K | $-234.0K | $-56.0K | |
| Stockholders' Equity | $33M | $-49M | $-31M | $5M | $74M | $244M | $393M | $636M | $123M | $68M | $131M | $104M | |
| Liabilities + Equity | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Shares Outstanding | 265,424,818 | 224,848,992 | 194,582,539 | 184,135,714 | 177,000,963 | 148,074,085 | 121,674,568 | 116,887,518 | 47,612,619 | 38,615,709 | 30,662,218 | 20,370,624 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $899.0K | $617.0K | $296.0K | $96.0K | $49.0K | |
| Stock-based Comp | $11M | $8M | $9M | $18M | $23M | $24M | $12M | $19M | $9M | $6M | $5M | $6M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $0 | $36M | $36M | $36M | $36M | $33M | $36M | $2M | · | · | · | · | |
| Restructuring | $0 | $58.0K | $181.0K | $16M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | $2M | $5M | $247M | $15M | $55M | $11M | $188M | · | · | |
| Operating Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-110M | $-257M | $-97M | $-56M | $58M | $-52M | $-27M | |
| CapEx | $291.0K | $33.0K | $0 | $114.0K | $59.0K | $317.0K | $7M | $2M | $2M | $3M | $414.0K | $229.0K | |
| Investing Cash Flow | $-8M | $-33.0K | $0 | $-114.0K | $40M | $-40M | $211M | $37M | $-177M | $13M | · | · | |
| Debt Issued | · | · | · | $0 | $0 | $20M | $78M | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $20M | $78M | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $162.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Financing Cash Flow | $73M | $50M | $-25M | $15M | $134M | $232M | $89M | $97M | $116M | $67M | · | · | |
| Net Change in Cash | $133M | $9M | $-49M | $-59M | $-79M | $81M | $43M | $36M | $-117M | $138M | $17M | $12M | |
| Free Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-111M | $-264M | $-99M | $-58M | $55M | $-53M | $-28M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 10.0% | -31.5% | -23.8% | -27.6% | -124.2% | -127.5% | -85.5% | -85.8% | · | · | · | · | |
| Net Margin | -2.3% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -83.5% | -69.1% | · | · | · | · | |
| Pretax Margin | -1.6% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -85.5% | -82.8% | · | · | · | · | |
| EBITDA Margin | 10.0% | -31.5% | -23.8% | -27.1% | -123.3% | -126.8% | -84.8% | -85.3% | · | · | · | · | |
| ROA | -1.8% | -30.0% | -19.9% | · | -48.4% | -54.2% | -31.6% | -21.1% | -23.2% | -61.3% | -47.8% | -50.8% | |
| ROE | -17.3% | 139.4% | 148.3% | · | -264.8% | -135.6% | -64.9% | -36.9% | -82.1% | -136.3% | -51.7% | 322.1% | |
| ROIC | 41.7% | · | · | · | -152.5% | -109.4% | -59.4% | -23.4% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.4 | 1.2 | · | 1.1 | 2.0 | 1.5 | 1.8 | 2.5 | 2.6 | 11.9 | 16.0 | |
| Quick Ratio | 1.4 | 1.1 | 0.8 | · | 0.8 | 1.4 | 0.9 | 0.5 | 2.4 | 2.3 | 11.7 | 15.8 | |
| Debt / Equity | 1.5 | -0.8 | -1.1 | · | 1.3 | 0.4 | 0.2 | · | · | · | · | · | |
| LT Debt / Equity | 1.5 | -0.8 | -0.6 | · | 0.0 | 0.4 | 0.2 | · | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | · | 0.4 | 0.4 | 0.4 | 0.3 | · | · | 0.0 | 0.0 | |
| Inventory Turnover | 2.5 | 4.0 | 4.1 | · | 3.1 | 3.3 | 0.9 | 0.1 | · | · | · | · | |
| Receivables Turnover | 5.8 | 4.3 | 6.7 | · | 5.5 | 9.0 | 12.1 | 8.2 | · | · | · | 0.0 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.12 | $-0.22 | $-0.16 | · | $0.43 | $1.67 | $3.24 | $5.44 | $2.51 | $1.76 | $4.27 | $5.11 | |
| Revenue / Share | $0.92 | $0.76 | $1.04 | $1.60 | $1.29 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.26 | $-0.19 | $-0.12 | $-0.40 | $-1.52 | · | · | · | · | · | · | · | |
| Cash / Share | $0.70 | $0.23 | $0.22 | · | $0.85 | $1.54 | $1.21 | $0.90 | $1.47 | $4.85 | $1.62 | $1.61 | |
| EPS (TTM) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | $-1.86 | $-1.86 | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 47.5% | -17.7% | -33.5% | 38.2% | -28.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -6.9% | -8.9% | -12.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -4.3% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Net Income TTM | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| Market Cap | $427M | $427M | $241M | · | $400M | $415M | $769M | $646M | $708M | $402M | $396M | $237M | |
| Enterprise Value | $291M | $414M | $233M | · | $348M | $282M | $697M | · | · | · | · | · | |
| P/E | -80.5 | -5.8 | -4.4 | -1.1 | -1.3 | -1.0 | -2.7 | -3.0 | -8.0 | · | · | · | |
| P/S | 1.8 | 2.7 | 1.2 | · | 1.9 | 1.4 | 2.3 | 3.1 | 3.9 | 261.9 | · | · | |
| P/B | 13.1 | -8.7 | -7.9 | · | 5.2 | 1.7 | 1.9 | 1.0 | 5.9 | 5.9 | 3.0 | 2.3 | |
| P / Tangible Book | · | · | · | · | · | 9.2 | · | · | · | · | · | · | |
| P / Cash Flow | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.8 | -3.0 | -6.6 | -12.6 | 6.9 | -7.6 | -8.6 | |
| P / FCF | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.7 | -2.9 | -6.5 | -12.3 | 7.3 | -7.5 | -8.6 | |
| EV / EBITDA | 12.4 | -8.2 | -5.0 | · | -1.3 | -0.8 | -2.5 | · | · | · | · | · | |
| EV / FCF | 4.3 | -10.2 | -10.0 | · | -1.4 | -2.5 | -2.6 | · | · | · | · | · | |
| EV / Revenue | 1.2 | 2.6 | 1.2 | · | 1.6 | 1.0 | 2.1 | · | · | · | · | · | |
| Earnings Yield | -1.2% | -17.4% | -22.6% | -90.1% | -75.2% | -99.3% | -37.3% | -33.6% | -12.5% | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49M | $54M | $58M | $59M | $62M | $57M | $46M | $37M | $44M | $33M | $56M | $42M | $56M | $40M | $56M | $49M | |
| Cost of Revenue | $10M | $12M | $13M | $9M | $10M | $8M | $20M | $14M | $17M | $12M | $19M | $18M | $17M | $20M | $-3M | $38M | |
| R&D Expense | $14M | $15M | $27M | $15M | $11M | $10M | $12M | $8M | $8M | $10M | $10M | $13M | $20M | $20M | $32M | $28M | |
| SG&A Expense | $28M | $30M | $26M | $29M | $27M | $26M | $28M | $27M | $27M | $25M | $25M | $23M | $27M | $25M | $30M | $32M | |
| Operating Expenses | $45M | $46M | $54M | $45M | $38M | $36M | $40M | $36M | $35M | $36M | $36M | $37M | $48M | $45M | $64M | $61M | |
| Operating Income | $-6M | $-5M | $-9M | $4M | $14M | $14M | $-14M | $-13M | $-9M | $-15M | $1M | $-13M | $-9M | $-26M | $-5M | $-50M | |
| Other Non-op | $-7.0K | $3.0K | $-117.0K | $-10.0K | $-28.0K | $213.0K | $55.0K | $-17.0K | $-39.0K | $95.0K | $658.0K | $-43.0K | $-10.0K | $282.0K | $434.0K | $1M | |
| Pretax Income | $-9M | $-9M | $-11M | $1M | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | · | · | |
| Income Tax | $70.0K | $126.0K | $1M | $615.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-9M | $-9M | $-12M | $540.0K | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | $-6M | $-54M | |
| EPS (Basic) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.04 | $-0.29 | |
| EPS (Diluted) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.03 | $-0.29 | |
| Shares (Basic) | 269,602,747 | 267,046,755 | · | 264,786,432 | 262,565,500 | 235,497,720 | · | 210,348,459 | 209,705,397 | 204,955,151 | · | 188,306,350 | 186,817,431 | 184,768,983 | · | 183,882,446 | |
| Shares (Diluted) | 269,602,747 | 267,046,755 | · | 274,372,722 | 271,104,020 | 241,602,853 | · | 210,348,459 | 209,705,397 | 204,955,151 | · | 188,306,350 | 186,817,431 | 184,768,983 | · | 183,882,446 | |
| EBITDA | $-6M | $-5M | · | $4M | $14M | $14M | · | $-13M | $-9M | $-15M | · | $-13M | $-9M | $-25M | · | $-48M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $163M | $185M | $166M | $137M | $113M | $52M | $34M | $39M | $42M | $43M | $47M | $54M | $57M | $90M | $145M | |
| Receivables | $54M | $63M | $47M | $66M | $73M | $62M | $34M | $32M | $30M | $27M | · | $23M | $20M | $18M | $40M | $23M | |
| Inventory | $13M | $13M | $16M | $19M | $17M | $20M | $16M | $20M | $24M | $26M | · | $18M | $21M | $21M | $22M | $40M | |
| Prepaid Expense | $7M | $5M | $5M | $7M | $8M | $9M | $11M | $13M | $19M | $19M | · | $22M | $24M | $25M | $33M | $30M | |
| Other Current Assets | $6M | $4M | $4M | $5M | $8M | $8M | $7M | $6M | $7M | $5M | · | · | · | · | $17M | · | |
| Current Assets | $230M | $243M | $253M | $258M | $235M | $204M | $114M | $100M | $112M | $113M | · | $110M | $118M | $121M | $185M | $238M | |
| PP&E (Net) | $2M | $956.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | · | $4M | $4M | $5M | $5M | $6M | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | · | $59M | $59M | $55M | $59M | $55M | |
| Intangibles | · | · | · | · | · | · | · | $9M | $18M | $27M | · | $45M | $54M | $63M | $72M | $81M | |
| Other Non-current Assets | $54M | $57M | $60M | $40M | $44M | $38M | $37M | $27M | $18M | $12M | · | $4M | $3M | $5M | $5M | $26M | |
| Total Assets | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Accounts Payable | $9M | $8M | $21M | $10M | $12M | $13M | $15M | $13M | $10M | $12M | · | $9M | $12M | $13M | $18M | $20M | |
| Accrued Liabilities | $110M | $125M | $122M | $106M | $92M | $71M | $63M | $52M | $54M | $54M | · | $63M | $56M | $46M | $76M | $87M | |
| Current Liabilities | $161M | $174M | $163M | $133M | $119M | $91M | $81M | $66M | $107M | $66M | · | $80M | $92M | $83M | $130M | $188M | |
| Capital Leases | $4M | · | $0 | $0 | $671.0K | $2M | $4M | $5M | $6M | $8M | · | $10M | $11M | $27M | $29M | $31M | |
| Other Non-current Liabilities | $562.0K | $681.0K | $2M | $5M | $5M | $5M | $5M | $5M | $7M | $7M | · | $9M | $17M | $13M | $16M | $74M | |
| Total Liabilities | $325M | $335M | $344M | $323M | $316M | $286M | $270M | $258M | $254M | $253M | · | $274M | $281M | $291M | $351M | $422M | |
| Long-term Debt | $50M | $49M | $48M | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | $66M | $66M | |
| Total Debt | $50M | $49M | · | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | · | $66M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-1.70B | $-1.69B | $-1.68B | $-1.67B | $-1.67B | $-1.67B | $-1.68B | $-1.66B | $-1.64B | $-1.63B | · | $-1.61B | $-1.60B | $-1.58B | $-1.56B | $-1.55B | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Stockholders' Equity | $25M | $27M | $33M | $42M | $29M | $25M | $-49M | $-50M | $-34M | $-27M | $-31M | $-39M | $-27M | $-14M | $5M | $14M | |
| Liabilities + Equity | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Shares Outstanding | 271,742,717 | 267,898,415 | 265,424,818 | 265,226,038 | 263,041,832 | 261,644,590 | 224,848,992 | 211,542,122 | 209,929,145 | 209,454,149 | 194,582,539 | 188,313,807 | 188,128,869 | 185,835,946 | 184,135,714 | 183,951,583 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | |
| Amort. of Intangibles | · | · | $0 | $0 | $0 | $0 | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Restructuring | $2M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $58.0K | $0 | $169.0K | $-94.0K | $106.0K | $1M | $180.0K | |
| Operating Cash Flow | $4M | $-21M | $31M | $28M | $22M | $-14M | $-4M | $-7M | $-10M | $-19M | $-2M | $-7M | $4M | $-18M | $-55M | $34M | |
| CapEx | $1M | $62.0K | $70.0K | $77.0K | $126.0K | $18.0K | $2.0K | $2.0K | $29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Investing Cash Flow | $-4M | $-62.0K | $-8M | $-77.0K | $-126.0K | $154.0K | $-2.0K | $-2.0K | $-29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $-7M | $-926.0K | $-5M | $1M | $2M | $75M | $22M | $1M | $8M | $18M | $-1M | $50.0K | $-8M | $-16M | $-1.0K | $-33M | |
| Net Change in Cash | $-7M | $-22M | $18M | $29M | $24M | $62M | $18M | $-5M | $-2M | $-957.0K | $-4M | $-7M | $-4M | $-34M | $-55M | $868.0K | |
| Free Cash Flow | · | $-21M | · | · | · | $-14M | · | · | · | · | · | · | · | $-18M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| Net Margin | -18.1% | -16.9% | · | 0.92% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | -34.5% | -19.8% | -65.3% | · | -105.9% | |
| Pretax Margin | -18.0% | -16.7% | · | 2.0% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | · | · | · | · | · | |
| EBITDA Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| ROA | -2.6% | -2.7% | · | 0.19% | 0.09% | 2.3% | · | -9.1% | -3.6% | -7.2% | · | -4.3% | -2.9% | -6.5% | · | -10.0% | |
| ROE | -32.9% | -34.8% | · | -12.3% | -10.9% | -456.6% | · | 44.6% | 28.3% | 86.5% | · | 113.3% | -62.9% | -445.7% | · | -68.7% | |
| ROIC | -8.6% | -6.2% | · | 2.3% | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.9 | 2.0 | 2.2 | · | 1.5 | 1.0 | 1.7 | · | 1.4 | 1.3 | 1.5 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.7 | 1.8 | 1.9 | · | 1.0 | 0.6 | 1.0 | · | 0.9 | 0.8 | 0.9 | · | 0.9 | |
| Debt / Equity | 2.0 | 1.8 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -1.1 | -1.6 | -3.5 | · | 4.8 | |
| LT Debt / Equity | 1.0 | 1.3 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -0.9 | -0.7 | -1.8 | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.3 | · | 0.7 | 0.8 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 1.0 | |
| Receivables Turnover | 0.8 | 0.9 | · | 1.2 | 1.2 | 1.3 | · | 1.4 | 1.8 | 1.5 | · | 1.8 | 1.1 | 1.0 | · | 1.3 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.09 | $0.10 | · | $0.16 | $0.11 | $0.09 | · | $-0.24 | $-0.16 | $-0.13 | · | $-0.21 | $-0.14 | $-0.08 | · | $0.08 | |
| Revenue / Share | $0.18 | $0.20 | · | $0.21 | $0.23 | $0.24 | · | $0.18 | $0.21 | $0.16 | · | $0.22 | $0.30 | $0.22 | · | $0.27 | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.06 | · | · | · | $-0.09 | · | · | · | $-0.09 | · | · | |
| Cash / Share | $0.57 | $0.61 | · | $0.63 | $0.52 | $0.43 | · | $0.16 | $0.19 | $0.20 | · | $0.25 | $0.28 | $0.31 | · | $0.79 | |
| EPS (TTM) | $-0.11 | $-0.08 | · | $-0.07 | $-0.17 | $-0.21 | · | $-0.22 | $-0.20 | $-0.22 | · | $-0.32 | $-0.53 | $-0.32 | · | $-0.89 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $219M | $232M | · | $225M | $204M | $185M | · | $170M | $174M | $187M | · | $194M | $201M | $271M | · | $294M | |
| Net Income TTM | $-30M | $-21M | · | $-16M | $-36M | $-45M | · | $-46M | $-40M | $-43M | · | $-59M | $-98M | $-58M | · | $-158M | |
| Market Cap | $310M | $372M | · | $724M | $957M | $502M | · | $279M | $214M | $383M | · | $215M | $172M | $104M | · | $58M | |
| Enterprise Value | $204M | $259M | · | $605M | $867M | $435M | · | $284M | $213M | $371M | · | $211M | $161M | $97M | · | $-21M | |
| P/E | -10.4 | -17.4 | · | -39.0 | -21.4 | -9.1 | · | -6.0 | -5.1 | -8.3 | · | -3.6 | -1.7 | -1.8 | · | -0.4 | |
| P/S | 1.4 | 1.6 | · | 3.2 | 4.7 | 2.7 | · | 1.6 | 1.2 | 2.0 | · | 1.1 | 0.9 | 0.4 | · | 0.2 | |
| P/B | 12.4 | 13.6 | · | 17.4 | 32.8 | 20.4 | · | -5.5 | -6.3 | -14.1 | · | -5.4 | -6.4 | -7.3 | · | 4.2 | |
| P / Cash Flow | · | -17.6 | · | · | · | -37.0 | · | · | · | -19.7 | · | · | · | -5.9 | · | · | |
| EV / Revenue | 0.9 | 1.1 | · | 2.7 | 4.3 | 2.4 | · | 1.7 | 1.2 | 2.0 | · | 1.1 | 0.8 | 0.4 | · | -0.1 | |
| Earnings Yield | -9.7% | -5.8% | · | -2.6% | -4.7% | -10.9% | · | -16.7% | -19.6% | -12.0% | · | -28.1% | -57.9% | -57.1% | · | -281.6% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | $236M | $160M | $195M | · | $292M |
| Operating Margin % | 10.0% | -31.5% | -23.8% | · | -27.6% |
| Net Income | $-5M | $-69M | $-52M | · | $-94M |
| Diluted EPS | $-0.02 | $-0.33 | $-0.28 | · | $-0.52 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 1.5 | -0.8 | -1.1 | · | · |
| Current Ratio | 1.6 | 1.4 | 1.2 | · | · |
| Quick Ratio | 1.4 | 1.1 | 0.8 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $68M | $-41M | $-23M | · | $-73M |
Institutional owners (13F) 181 filers · $144.4M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
181
Value held
$144.4M
New positions
39
Exited positions
35
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 39 (+4 vs prior Q) | 35 (+8 vs prior Q) | 68 (+25 vs prior Q) | 34 (-20 vs prior Q) | +6.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $25,786,481 | 16,016,448 | 17.86% | Shares |
| BlackRock, Inc. | $22,784,466 | 19,986,374 | 15.78% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $12,907,243 | 11,322,143 | 8.94% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $10,432,737 | 9,151,524 | 7.23% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $7,671,148 | 6,727,302 | 5.31% | Shares |
| STATE STREET CORP | $6,145,572 | 5,390,853 | 4.26% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4,871,250 | 4,273,026 | 3.37% | Shares |
| GOLDMAN SACHS GROUP INC | $4,205,650 | 3,689,167 | 2.91% | Shares |
| MILLENNIUM MANAGEMENT LLC | $3,644,130 | 3,196,605 | 2.52% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,888,734 | 2,533,977 | 2.00% | Shares |
| TWO SIGMA INVESTMENTS, LP | $2,777,807 | 2,436,673 | 1.92% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2,622,499 | 2,300,438 | 1.82% | Shares |
| NORTHERN TRUST CORP | $2,462,816 | 2,160,365 | 1.71% | Shares |
| Nantahala Capital Management, LLC | $2,280,000 | 2,000,000 | 1.58% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,176,029 | 1,908,797 | 1.51% | Shares |
| FMR LLC | $2,133,008 | 1,871,059 | 1.48% | Shares |
| Qube Research & Technologies Ltd | $2,028,866 | 1,779,707 | 1.41% | Shares |
| CITADEL ADVISORS LLC | $1,958,131 | 1,717,659 | 1.36% | Shares |
| UBS Group AG | $1,567,442 | 1,374,950 | 1.09% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,395,318 | 1,223,963 | 0.97% | Shares |
| CITIGROUP INC | $1,282,010 | 1,124,570 | 0.89% | Shares |
| MORGAN STANLEY | $799,756 | 701,540 | 0.55% | Shares |
| Invesco Ltd. | $792,218 | 694,928 | 0.55% | Shares |
| MANGROVE PARTNERS IM, LLC | $760,328 | 666,954 | 0.53% | Shares |
| AMERIPRISE FINANCIAL INC | $713,823 | 626,160 | 0.49% | Shares |
| Bank of New York Mellon Corp | $705,830 | 619,149 | 0.49% | Shares |
| Nuveen, LLC | $680,123 | 596,599 | 0.47% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $672,396 | 589,821 | 0.47% | Shares |
| TWO SIGMA ADVISERS, LP | $643,918 | 399,949 | 0.45% | Shares |
| CHOREO, LLC | $641,162 | 562,423 | 0.44% | Shares |
| Quantinno Capital Management LP | $640,820 | 562,123 | 0.44% | Shares |
| Creative Planning | $622,144 | 545,740 | 0.43% | Shares |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $606,265 | 531,813 | 0.42% | Shares |
| PANAGORA ASSET MANAGEMENT INC | $531,832 | 466,519 | 0.37% | Shares |
| BANK OF AMERICA CORP /DE/ | $522,976 | 458,750 | 0.36% | Shares |
| ALLIANCEBERNSTEIN L.P. | $493,325 | 354,910 | 0.34% | Shares |
| Eversept Partners, LP | $486,888 | 427,095 | 0.34% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $408,376 | 358,627 | 0.28% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $368,904 | 323,600 | 0.26% | Shares |
| VIRTUS ADVISERS, LLC | $359,940 | 315,737 | 0.25% | Shares |
| RHUMBLINE ADVISERS | $350,544 | 307,503 | 0.24% | Shares |
| Russell Investments Group, Ltd. | $342,416 | 300,367 | 0.24% | Shares |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $336,186 | 294,900 | 0.23% | Shares |
| ALPS ADVISORS INC | $310,379 | 272,262 | 0.22% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $304,722 | 267,300 | 0.21% | Put option |
| JPMORGAN CHASE & CO | $298,634 | 269,040 | 0.21% | Shares |
| DEUTSCHE BANK AG\ | $292,847 | 256,883 | 0.20% | Shares |
| FRANKLIN RESOURCES INC | $286,156 | 251,014 | 0.20% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $279,072 | 244,800 | 0.19% | Call option |
| WELLS FARGO & COMPANY/MN | $270,084 | 236,916 | 0.19% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Muneer A. Satter (2) ×3 filings | Jan. 11, 2019 | · | Initial filing | M&A / sale | SEC |
| Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack ×2 filings | Dec. 21, 2018 | · | Initial filing | Passive investment | SEC |
| Vifor (International) Ltd., Vifor Pharma Ltd. ×2 filings | Aug. 10, 2017 | · | Initial filing | · | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Thomas Weisel Healthcare Venture Partners, L.P. (“TWHVP”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 filings | Jan. 20, 2016 | · | Initial filing | · | SEC |
| Novo A/S ×3 filings | Nov. 18, 2015 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 38 insiders · 17 officers · 20 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| John P. Butler | CEO and President | Aug. 6, 2026 M | 3,718,564 | 1 | 4 | $-387,825 |
| Erik Ostrowski | SVP, CFO, CBO & Treasurer | June 29, 2026 S | 616,616 | 0 | 2 | $-110,763 |
| Ellen Snow | SVP, CFO and Treasurer | Jan. 31, 2024 A | 519,300 | 0 | 0 | $0 |
| David A Spellman | SVP, CFO and Treasurer | May 16, 2023 S | 446,483 | 0 | 0 | $0 |
| Jason Amello | SVP, CFO & Treasurer | Feb. 28, 2020 A | 144,642 | 0 | 0 | $0 |
| Michel Dahan | SVP, Chief Operating Officer | May 13, 2024 S | 672,092 | 0 | 0 | $0 |
| Carolyn M. Rucci | SVP, Chief Legal Officer | Feb. 2, 2026 S | 588,378 | 0 | 3 | $-96,983 |
| Richard C Malabre | SVP, Chief Accounting Officer | Feb. 2, 2026 S | 299,390 | 0 | 2 | $-68,838 |
| Nicholas Grund | Chief Commercial Officer | Feb. 2, 2026 S | 561,750 | 0 | 2 | $-117,912 |
| Steven Keith Burke | SVP, Chief Medical Officer | Feb. 2, 2026 S | 948,432 | 0 | 3 | $-94,044 |
| Nicole R. Hadas | SVP, Chief Legal Officer | May 13, 2024 S | 651,243 | 0 | 0 | $0 |
| Violetta Cotreau | SVP, Chief Accounting Officer | May 12, 2022 A | 219,954 | 0 | 0 | $0 |
| Dell Faulkingham | SVP, CCO | Feb. 28, 2022 A | 173,841 | 0 | 0 | $0 |
| Karen L Tubridy | SVP, Chief Development Officer | Feb. 28, 2020 A | 84,679 | 0 | 0 | $0 |
| Rita Jain | SVP, Chief Medical Officer | April 11, 2019 D | 96,332 | 0 | 0 | $0 |
| Bradley Maroni | SVP and Chief Medical Officer | Feb. 21, 2017 A | 64,585 | 0 | 0 | $0 |
| Robert Shalwitz | Chief Medical Officer | May 14, 2014 A | 264,556 | 0 | 0 | $0 |
| Ron Frieson | Director | June 17, 2026 A | 165,200 | 0 | 0 | $0 |
| Myles Wolf | Director | June 17, 2026 A | 169,081 | 0 | 0 | $0 |
| Cynthia Smith | Director | June 17, 2026 A | 196,633 | 0 | 0 | $0 |
| Adrian Adams | Director | June 17, 2026 A | 236,200 | 0 | 0 | $0 |
| Michael W Rogers | Director | June 17, 2026 A | 197,429 | 0 | 0 | $0 |
| Leanne M Zumwalt | Director | June 17, 2026 A | 145,100 | 0 | 0 | $0 |
| Philip J. Vickers | Director | April 1, 2026 A | · | 0 | 0 | $0 |
| Steven C Gilman | Director | June 10, 2025 A | 152,830 | 0 | 0 | $0 |
| Michael Thomas Heffernan | Director | June 2, 2021 A | 48,586 | 0 | 0 | $0 |
| Mark J Enyedy | Director | June 5, 2020 A | 31,143 | 0 | 0 | $0 |
| Maxine Gowen | Director | June 5, 2020 A | 24,133 | 0 | 0 | $0 |
| Jodie Pope Morrison | Director | June 6, 2019 A | 58,619 | 0 | 0 | $0 |
| Scott A Canute | Director | June 6, 2019 A | 13,700 | 0 | 0 | $0 |
| Michael D. Clayman | Director | June 14, 2018 A | · | 0 | 0 | $0 |
| Duane Nash | Director | June 14, 2018 A | 21,499 | 0 | 0 | $0 |
| Ronald C Renaud JR | Director | June 14, 2018 A | 5,000 | 0 | 0 | $0 |
| Satter Muneer A | Director | June 14, 2018 A | 3,037,042 | 0 | 0 | $0 |
| Michael S Wyzga | Director | June 14, 2018 A | 1,500 | 0 | 0 | $0 |
| Anupam Dalal | Director | June 16, 2016 A | · | 0 | 0 | $0 |
| Novo Holdings A/S | · | March 25, 2014 C | 1,516,387 | 0 | 0 | $0 |
| Novartis Bioventures Ltd | · | March 25, 2014 C | 3,405,764 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 17 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.35% | 125,667 SH | Oct. 23, 2026 | Daily |
| IWC · iShares Trust | 0.06% | 873,651 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 249,458 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 2,169,896 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 123,445 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 1,485,665 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 438,631 SH | Oct. 23, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 6,668,524 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 364,328 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 46,198 SH | Sept. 3, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 3,164,884 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 7,912,283 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 24,210 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 20,230 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.00% | 754,414 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 338,893 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 623,464 SH | Sept. 11, 2026 | Daily |
AKBA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$4.00
+475.7%
4 33.3%
Strong Buy
6 50.0%
Buy
2 16.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-10-24Mean target $3.92 +463.7%
← Below all targets
Current price $0.69
Low$1.00
Mean$3.92
High$6.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| YARW | · | · | · | · | · | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026